KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Current Assets: 2009-2025

Historic Current Assets for Ionis Pharmaceuticals (IONS) over the last 16 years, with Sep 2025 value amounting to $2.5 billion.

  • Ionis Pharmaceuticals' Current Assets fell 7.18% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year decrease of 7.18%. This contributed to the annual value of $2.6 billion for FY2024, which is 0.82% down from last year.
  • According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Current Assets is $2.5 billion, which was down 2.26% from $2.6 billion recorded in Q2 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Current Assets peaked at $2.7 billion during Q3 2024, and registered a low of $2.0 billion during Q1 2021.
  • Moreover, its 3-year median value for Current Assets was $2.6 billion (2025), whereas its average is $2.5 billion.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Current Assets fell by 22.23% in 2021, and later rose by 20.10% in 2023.
  • Over the past 5 years, Ionis Pharmaceuticals' Current Assets (Quarterly) stood at $2.3 billion in 2021, then declined by 6.07% to $2.2 billion in 2022, then grew by 19.94% to $2.6 billion in 2023, then declined by 0.82% to $2.6 billion in 2024, then fell by 7.18% to $2.5 billion in 2025.
  • Its Current Assets stands at $2.5 billion for Q3 2025, versus $2.6 billion for Q2 2025 and $2.4 billion for Q1 2025.